HALDOL Safety Questions, HALDOL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about HALDOL. Our extensive database of HALDOL adverse events and HALDOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about HALDOL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




HALDOL Safety Reports

Total HALDOL reports: 204.
HALDOL FDA safety alerts: 2007 .
Reported deaths: 17    Reported hospitalizations: 96.
Take HALDOL Side Effects Survey or Share Your HALDOL Story. HALDOL Usage.

Showing 1-75 of 204 Next >

Physician from BRAZIL reported HALDOL problem on May 20, 2007. Male patient, 22 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension, overdose, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from BRAZIL on May 29, 2007. Female patient, 28 years of age, weighting 176.4 lb, was diagnosed with sedation and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, mutism. HALDOL dosage: unknown. Patient recovered.

Consumer or non-health professional from BRAZIL reported HALDOL problem on May 28, 2007. Male patient, 23 years of age, weighting 143.0 lb, was diagnosed with nervousness, agitation, depression and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: muscle disorder, weight increased. HALDOL dosage: unknown. During the same period patient was treated with VITASAY STRESS. Patient recovered.

HALDOL problem was reported by a Physician from UNITED STATES on June 06, 2007. Male patient, 50 years of age, weighting 260.0 lb, was diagnosed with psychotic disorder, hypertension and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, confusional state, hypokinesia, mental impairment, social avoidant behaviour. HALDOL dosage: unknown. During the same period patient was treated with RISPERDAL. Patient recovered.

Physician from BRAZIL reported HALDOL problem on June 07, 2007. Female patient, child 10 years of age, weighting 28.66 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, myalgia. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on June 07, 2007. Female patient, child 10 years of age, weighting 61.73 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: dyskinesia, eye movement disorder, overdose. HALDOL dosage: unknown. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on June 13, 2007. Female patient, 76 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: fall. HALDOL dosage: unknown. During the same period patient was treated with MODOPAR LP, LEXOMIL, NOCTRAN, EFFEXOR, NEXIUM, SIMVASTATIN, FORLAX. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on June 17, 2007. Male patient, 49 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: overdose, sinus bradycardia, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with DIAZEPAM, PROPRANOLOL, TROXERUTINA, CUMARINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HALDOL problem on Apr 13, 2007. Male patient was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, overdose. HALDOL dosage: 1 TO 3 VIALS (50 MG/ML STRENGTH). Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Male patient, 47 years of age, weighting 148.0 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, convulsion, epistaxis, hypertension, joint swelling, weight increased. HALDOL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HALDOL problem on Oct 03, 2006. Male patient, 34 years of age, weighting 155.0 lb, was diagnosed with bipolar i disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from UNITED STATES on June 22, 2006. Female patient, 58 years of age, was diagnosed with schizoaffective disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: agitation, neuroleptic malignant syndrome. HALDOL dosage: unknown. During the same period patient was treated with RISPERDAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HALDOL problem on July 18, 2006. Female patient, 58 years of age, weighting 165.0 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: decreased appetite, dry mouth, eye disorder, memory impairment, muscle twitching, tremor, weight decreased. HALDOL dosage: 100 MG, 1 IN 1 MONTH, INTRAMUSCULAR. During the same period patient was treated with RISPERDAL, COGENTIN, EFFEXOR, PHENERGAN, TRAMADOL. Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2006. Male patient, 59 years of age, weighting 263.0 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: agitation, mental disorder, schizophrenia, tremor. HALDOL dosage: unknown. During the same period patient was treated with POTASSIUM, LASIX, LAMICTAL, CRESTOR, MESORIDAZINE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported HALDOL problem on June 22, 2007. Male patient, 50 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: akathisia, depressive symptom, restless legs syndrome, suicidal ideation, tardive dyskinesia. HALDOL dosage: unknown. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from GERMANY on June 22, 2007. Female patient, 47 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: akathisia. HALDOL dosage: unknown. During the same period patient was treated with MELNEURIN, PANTOZOL, DISALUNIL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported HALDOL problem on June 20, 2007. Male patient, 28 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: angioedema. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on June 21, 2007. Female patient, 54 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with AKINETON, DIAZEPAM, FENERGAN, AMPLICTIL. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on June 22, 2007. Male patient, 85 years of age, was diagnosed with bacterial sepsis and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. HALDOL dosage: unknown. During the same period patient was treated with NOROXIN. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on June 23, 2007. Male patient, child 10 years of age, weighting 46.30 lb, was diagnosed with chorea, convulsion, upper respiratory tract infection and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: agitation, hyperthermia, hypertonia, muscle rigidity, opisthotonus. HALDOL dosage: unknown. During the same period patient was treated with PENICILLIN. Patient recovered.

Physician from BRAZIL reported HALDOL problem on June 24, 2007. Female patient, 60 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt, tremor. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from GERMANY on June 26, 2006. Female patient, 35 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. HALDOL dosage: unknown. During the same period patient was treated with CLOZAPINE, SEROQUEL, TAVOR. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on June 26, 2006. Male patient, 60 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood bicarbonate increased, blood ph decreased, chronic obstructive pulmonary disease, cough, dyspnoea, hypercapnia, incorrect dose administered, lung disorder. HALDOL dosage: unknown. During the same period patient was treated with NOZINAN, HEPTAMYL, AKINETON. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Health Professional from GERMANY on June 26, 2006. Female patient, 38 years of age, weighting 281.8 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: weight increased. HALDOL dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ENAHEXAL, HCT HEXAL. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported HALDOL problem on June 26, 2006. Female patient, 38 years of age, weighting 147.7 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: back pain, deep vein thrombosis, pneumonia, pulmonary embolism, pulmonary infarction, tachycardia. HALDOL dosage: unknown. During the same period patient was treated with TAVOR, AKINETON RET, JODTHYROX. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on June 28, 2006. Male patient, 16 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: dystonia. HALDOL dosage: unknown. Patient recovered.

Health Professional from GERMANY reported HALDOL problem on June 30, 2006. Female patient, weighting 156.5 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: skin laceration. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from BRAZIL on July 06, 2006. Male patient, 19 years of age, weighting 132.3 lb, was diagnosed with nervous system disorder, hypertension, panic disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: fatigue, nasopharyngitis, somnolence. HALDOL dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient was hospitalized. Patient recovered.

Physician from SWEDEN reported HALDOL problem on July 10, 2006. Female patient, 67 years of age, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, renal failure. HALDOL dosage: 2-8MG DAILY. During the same period patient was treated with LITHIONIT, ZYPREXA, PROPAVAN, ERGENYL RETARD. Patient recovered.

HALDOL problem was reported by a Health Professional from FRANCE on July 12, 2006. Female patient, 66 years of age, was diagnosed with schizotypal personality disorder, sleep disorder, epilepsy, embolism venous and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: fall. HALDOL dosage: HALOPERIDOL DOSE READJUSTED TO 7.5MG IN THE MORNING AND 5MG IN THE EVENING.. During the same period patient was treated with IMOVANE, TERCIAN, NEURONTIN, DEPAMIDE, COUMADIN. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on July 12, 2006. Male patient, 60 years of age, was diagnosed with psychotic disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental overdose, coma, dyspnoea, hypoaesthesia, somnolence. HALDOL dosage: unknown. During the same period patient was treated with NOZINAN, HEPTAMYL, AKINETON. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on July 11, 2006. Female patient, 57 years of age, weighting 154.3 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: suicide attempt. HALDOL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported HALDOL problem on July 25, 2006. Male patient, 58 years of age, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: anaemia, leukopenia, myelodysplastic syndrome. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, weighting 130.0 lb, was diagnosed with anxiety, discomfort, nausea and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: ovarian cancer metastatic, respiratory failure, weight increased. HALDOL dosage: 2 MG EVERY 8 HOURS AS NEEDED (PRN). During the same period patient was treated with DURAGESIC, DILAUDID, ATIVAN, BENADRYL. Patient died on 04/13/2004.

Physician from SWITZERLAND reported HALDOL problem on July 26, 2006. Male patient, 38 years of age, was diagnosed with schizotypal personality disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: laryngeal oedema, respiratory distress. HALDOL dosage: unknown. During the same period patient was treated with ZYPREXA, PRAZINE. Patient was hospitalized. Patient died on 03/16/2006.

HALDOL problem was reported by a Physician from BRAZIL on July 26, 2006. Female patient, child 5 years of age, was diagnosed with accidental exposure and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, miosis, tachycardia, tremor. HALDOL dosage: unknown. During the same period patient was treated with CHLORPROMAZINE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported HALDOL problem on July 26, 2006. Male patient, child 5 years of age, weighting 57.32 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, hypertonia, muscle spasms, somnolence. HALDOL dosage: CONTENTS OF ONE FLASK, 30 ML OF 2 MG/ML. Patient recovered.

HALDOL problem was reported by a Pharmacist from FRANCE on July 31, 2006. Male patient was diagnosed with psychotic disorder, affective disorder, agitation and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: overdose. HALDOL dosage: 6 VIALS = 300MG. During the same period patient was treated with TERCIAN, DEPAKOTE, SERESTA, ATARAX. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported HALDOL problem on July 31, 2006. Male patient, 39 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, muscle contractions involuntary, somnolence, suicide attempt. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from UNITED STATES on Aug 09, 2006. Male patient, weighting 217.0 lb, was diagnosed with agitation, bipolar disorder, mania and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: dystonia, jaw disorder. HALDOL dosage: 5 MG PO Q4 HOURS PRN FOR AGITATION [RECEIVED IN 1ST 24 HOURS OF HOSPITALIZATION THEN STOPPED]. During the same period patient was treated with DIPHENHYRADMINE. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on Aug 04, 2006. Female patient, 85 years of age, was diagnosed with depression, hypertension and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, disorientation, urinary retention. HALDOL dosage: unknown. During the same period patient was treated with EFFEXOR, SECTRAL, XANAX, DIPIPERON, ADALIX. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on July 31, 2006. Female patient, 39 years of age, weighting 165.3 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, muscular weakness, suicide attempt, vertigo. HALDOL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported HALDOL problem on Aug 07, 2006. Male patient, 79 years of age, weighting 121.3 lb, was diagnosed with oedema, cardiac failure, hypertension, hypokalaemia, cerebrovascular accident prophylaxis, thrombosis and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. HALDOL dosage: unknown. During the same period patient was treated with PHENERGAN, FUROSEMIDE, DIGOXIN, CAPTOPRIL, POTASSIUM CHLORIDE, ACETYLSALICYLIC ACID SRT, ACETYLSALICYLIC ACID SRT. Patient died on 08/04/2006.

HALDOL problem was reported by a Physician from BRAZIL on Aug 07, 2006. Female patient, 48 years of age, weighting 132.3 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, mydriasis, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with NITRAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported HALDOL problem on Aug 14, 2006. Female patient, 38 years of age, weighting 281.8 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: weight increased. HALDOL dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ENAHEXAL, HCT HEXAL. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Health Professional from GERMANY on Aug 14, 2006. Female patient, 38 years of age, weighting 147.7 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: back pain, coronary artery embolism, deep vein thrombosis, pneumonia, pulmonary embolism, sedation, tachycardia. HALDOL dosage: unknown. During the same period patient was treated with TAVOR, AKINETON RET, JODTHYROX. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported HALDOL problem on Aug 15, 2006. Male patient, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with PARKINANE. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Aug 14, 2006. Male patient, 46 years of age, weighting 154.3 lb, was diagnosed with alcoholism, suicide attempt and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, miosis, overdose, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with CHLORPROMAZINE. Patient recovered.

Physician from BRAZIL reported HALDOL problem on Aug 22, 2006. Male patient, child 2 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: apathy, decreased activity, miosis, somnolence. HALDOL dosage: unknown. During the same period patient was treated with IMIPRAMINE. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from BRAZIL on Aug 24, 2006. Male patient, 41 years of age, weighting 147.7 lb, was diagnosed with mental disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: hospitalisation, insomnia, nervousness, weight increased. HALDOL dosage: unknown. During the same period patient was treated with HALOPERIDOL DECANOATE, CHLORPROMAZINE, FENERGAN, DIAZEPAM. Patient was hospitalized. Patient recovered.

Physician from SWITZERLAND reported HALDOL problem on Sept 01, 2006. Male patient, 38 years of age, was diagnosed with schizotypal personality disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: laryngeal oedema, respiratory distress. HALDOL dosage: unknown. During the same period patient was treated with ZYPREXA, PRAZINE. Patient was hospitalized. Patient died on 03/16/2006.

HALDOL problem was reported by a Physician from BRAZIL on Aug 31, 2006. Female patient, child 3 years of age, weighting 35.27 lb, was diagnosed with accidental exposure and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, hypertonia. HALDOL dosage: unknown. Patient recovered.

Physician from BRAZIL reported HALDOL problem on Sept 04, 2006. Female patient, 22 years of age, weighting 110.2 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, overdose, suicide attempt. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Consumer or non-health professional from BRAZIL on Sept 04, 2006. Male patient, 28 years of age, weighting 154.3 lb, was diagnosed with aggression, cardiac disorder, hypertension, diabetes mellitus and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. HALDOL dosage: unknown. During the same period patient was treated with DIGOXIN, CAPTOPRIL, INSULIN, FENERGAN. Patient died on 09/03/2006.

Health Professional from SWEDEN reported HALDOL problem on Sept 11, 2006. Female patient, 41 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: hallucination, hallucination, visual, poisoning, subdural haematoma, suicide attempt, ventricular extrasystoles, ventricular tachycardia. HALDOL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, CISORDINOL, NITRAZEPAM. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Pharmacist from UNITED STATES on Sept 20, 2006. Female patient, 55 years of age, was diagnosed with psychotic disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. HALDOL dosage: 5 MG X 2 FEW HOURS APART IV. Patient recovered.

Physician from BRAZIL reported HALDOL problem on Sept 14, 2006. Female patient, child 2 years of age, was diagnosed with accidental exposure and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: overdose, somnolence. HALDOL dosage: unknown. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Sept 17, 2006. Female patient, 29 years of age, weighting 165.3 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: overdose, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient recovered.

Pharmacist from UNITED STATES reported HALDOL problem on Sept 28, 2006. Male patient, 48 years of age, weighting 173.5 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. HALDOL dosage: 500 MG 1 TIME IM. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from FRANCE on Sept 18, 2006. Female patient, weighting 169.8 lb, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: sleep apnoea syndrome, weight increased. HALDOL dosage: unknown. Patient recovered.

Physician from GERMANY reported HALDOL problem on Sept 27, 2006. Male patient, 46 years of age, weighting 160.9 lb, was diagnosed with schizophrenia, paranoid type, extrapyramidal disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: deafness. HALDOL dosage: unknown. During the same period patient was treated with HALDOL SOLUTAB, AKINETON. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Oct 01, 2006. Male patient, child 4 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: coma, miosis, respiratory disorder. HALDOL dosage: unknown. During the same period patient was treated with CLONAZEPAM, BIPERIDEN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported HALDOL problem on Oct 03, 2006. Female patient, child 9 years of age, weighting 101.4 lb, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: accidental overdose, dysphonia, hypertonia. HALDOL dosage: unknown. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Oct 18, 2006. Male patient, 40 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: catatonia, physical assault, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with FLUOXETINE, CHLORPROMAZINE, LITHIUM CARBONATE, DIAZEPAM. Patient recovered.

Consumer or non-health professional from GERMANY reported HALDOL problem on Oct 17, 2006. Female patient, 35 years of age, was diagnosed with mania and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: confusional state, constipation, depression, suicide attempt, urinary retention. HALDOL dosage: unknown. Patient was hospitalized. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Oct 26, 2006. Female patient, 33 years of age, weighting 143.3 lb, was diagnosed with suicide attempt and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with PHENOBARBITAL, DIAZEPAM, AMITRIPTYLINE. Patient recovered.

Consumer or non-health professional from BRAZIL reported HALDOL problem on Oct 30, 2006. Male patient, child 5 years of age, weighting 46.30 lb, was diagnosed with adverse event, attention deficit/hyperactivity disorder, convulsion, bipolar disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: overdose, somnolence. HALDOL dosage: unknown. During the same period patient was treated with RITALIN, RIVOTRIL. Patient recovered.

HALDOL problem was reported by a Physician from GERMANY on Nov 06, 2006. Male patient, 40 years of age, was diagnosed with schizophrenia and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: parkinsonism. HALDOL dosage: unknown. During the same period patient was treated with RISPERDAL. Patient recovered.

Physician from GERMANY reported HALDOL problem on Nov 06, 2006. Male patient, 19 years of age, weighting 99.21 lb, was diagnosed with schizoaffective disorder and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, polydipsia psychogenic, rhabdomyolysis. HALDOL dosage: unknown. During the same period patient was treated with TAVOR, DIAZEPAM. Patient recovered.

HALDOL problem was reported by a Pharmacist from SWITZERLAND on Nov 08, 2006. Female patient, 80 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion. HALDOL dosage: unknown. During the same period patient was treated with ZOLOFT. Patient recovered.

Physician from BRAZIL reported HALDOL problem on Nov 13, 2006. Female patient, 26 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient recovered.

HALDOL problem was reported by a Physician from BRAZIL on Nov 11, 2006. Female patient, 39 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, somnolence, suicide attempt. HALDOL dosage: unknown. During the same period patient was treated with LEVOFLOXACIN, CARBAMAZEPINE. Patient recovered.

Consumer or non-health professional from BRAZIL reported HALDOL problem on Nov 16, 2006. Female patient, 94 years of age, was diagnosed with promotion of peripheral circulation, dementia alzheimer's type and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: aspiration bronchial, dementia alzheimer's type, multi-organ failure. HALDOL dosage: unknown. During the same period patient was treated with AMLODIPINE, NEOZINE, EXELON. Patient was hospitalized. Patient died on 11/12/2006.

HALDOL problem was reported by a Physician from GERMANY on Nov 15, 2006. Male patient, 25 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: thrombosis. HALDOL dosage: unknown. During the same period patient was treated with MELLARIL, ERGENYL, ESCITALOPRAM OXALATE, NEXIUM. Patient recovered.

Health Professional from FRANCE reported HALDOL problem on Nov 21, 2006. Male patient, 54 years of age, was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine increased, blood creatine phosphokinase increased, blood urea increased, dehydration, fall, heart rate abnormal, hypotension. HALDOL dosage: unknown. During the same period patient was treated with LEPTICUR, THERALENE, ZYPREXA, DEPAKENE. Patient died on 07/26/2006.

Showing 1-75 of 204 Next >

Ask Our Patient Community about HALDOL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)